Testing effectiveness (Phase 2)Study completedNCT01836471What this trial is testingAssess the Effect of QAW039 in Non-atopic Asthmatic PatientsWho this might be right forAsthma Novartis Pharmaceuticals 345
Large-scale testing (Phase 3)Study completedNCT00809172What this trial is testingStudy of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis PatientsWho this might be right forAtopic Dermatitis Hospices Civils de Lyon 100
Testing effectiveness (Phase 2)Study completedNCT02004119What this trial is testingPhase 2 Study of KHK4577Who this might be right forAtopic Dermatitis Kyowa Kirin Co., Ltd. 93
Early research (Phase 1)Study completedNCT01596712What this trial is testingSafety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of QGE031 in Japanese Atopic Male SubjectsWho this might be right forAllergy Novartis Pharmaceuticals 209
Post-approval studies (Phase 4)Study completedNCT00139581What this trial is testingComparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric SubjectsWho this might be right forAtopic Dermatitis Novartis
Not applicableUnknownNCT05078294What this trial is testingResults in Real Clinical Practice of Treatment of Moderate-severe Atopic DermatitisWho this might be right forDermatitis, Atopic Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 300
Early research (Phase 1)Study completedNCT04668066What this trial is testingStudy to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic DermatitisWho this might be right forAtopic Dermatitis Pfizer 121
Large-scale testing (Phase 3)Study completedNCT03745651What this trial is testingTRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic DermatitisWho this might be right forAtopic Dermatitis Incyte Corporation 618
Post-approval studies (Phase 4)WithdrawnNCT03710044What this trial is testingInvestigation of Flare and Remission in Subjects With Atopic DermatitisWho this might be right forAtopic Dermatitis LEO Pharma
Not applicableStudy completedNCT00929981What this trial is testingAssess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian PatientsWho this might be right forDermatitis, Contact Pfizer 80
Testing effectiveness (Phase 2)Study completedNCT07712536What this trial is testingPhase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic DermatitisWho this might be right forAdolescent Participants With Moderate to Severe Atopic Dermatitis (AD) E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 24
Not applicableEnrolling By InvitationNCT03976622What this trial is testingAnalysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia AreataWho this might be right forVitiligoPsoriasisAlopecia Areata+1 more University Hospital, Bordeaux 450
Not applicableUnknownNCT05636839What this trial is testingUVB-induced Treg Cells Exert Antigen-specific Suppression Through LAG-3Who this might be right forPsoriasisAtopic Dermatitis National Taiwan University Hospital 20
Not applicableStudy completedNCT03997175What this trial is testingEffect of Modified Playground Environment on Health, Particularly Immune SystemWho this might be right forAtopic DisordersImmune System Diseases University of Helsinki 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT07011706What this trial is testingATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic DermatitisWho this might be right forAtopic DermatitisAtopicDermatitis+2 more Aclaris Therapeutics, Inc. 110
Not applicableStudy completedNCT01591785What this trial is testingTreatment of Staphylococcus Aureus Colonization in Hand EczemaWho this might be right forHand EczemaFoot Eczema Gary Goldenberg 60
Not applicableActive Not RecruitingNCT05387980What this trial is testingLearn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.Who this might be right forAtopic Dermatitis Pfizer 1,128
Large-scale testing (Phase 3)Not Yet RecruitingNCT06884891What this trial is testingA Phase Ⅲ Comparative Study of QL2108 to Dupixent®Who this might be right forAtopic Dermatitis Qilu Pharmaceutical Co., Ltd. 520
Large-scale testing (Phase 3)Study completedNCT03349060What this trial is testingStudy to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic DermatitisWho this might be right forDermatitis, Atopic Pfizer 387
Early research (Phase 1)Study completedNCT01428297What this trial is testingA Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton SyndromeWho this might be right forHealthy VolunteersAtopic DermatitisNetherton Syndrome Novartis Pharmaceuticals 12